Tevogen Bio Holdings Inc.
TVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $404 | $378 | $0 | $0 |
| Gross Profit | -$404 | -$378 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $31,033 | $4,404 | $0 | $2,956 |
| G&A Expenses | $0 | $0 | $0 | $1,663 |
| SG&A Expenses | $22,128 | $4,061 | $953 | $1,663 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $53,161 | $8,465 | $953 | $4,618 |
| Operating Income | -$53,564 | -$8,843 | -$953 | -$4,618 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $39,837 | -$51,635 | $5,361 | -$10,978 |
| Pre-Tax Income | -$13,727 | -$60,478 | $4,408 | -$15,597 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,114 | -$60,478 | $4,408 | -$15,597 |
| % Margin | – | – | – | – |
| EPS | -0.094 | -0 | 0.037 | -0.33 |
| % Growth | -23,300% | -101.1% | 111.1% | – |
| EPS Diluted | -0.094 | -0 | 0.037 | -0.33 |
| Weighted Avg Shares Out | 146,673 | 165,421 | 120,000 | 47,933 |
| Weighted Avg Shares Out Dil | 146,673 | 165,421 | 120,000 | 47,933 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $184 | $256 | $0 | $599 |
| Depreciation & Amortization | $404 | $378 | $0 | $9 |
| EBITDA | -$13,140 | -$58,893 | $4,408 | -$14,989 |
| % Margin | – | – | – | – |